ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients

被引：3
|
作者：
Liu, Dingxie [1 ]
Hao, Qiongyu [2 ,3 ]
Li, Jieqing [2 ,3 ,4 ,5 ]
Li, Qun [6 ]
Wang, Kun [4 ,5 ]
Geng, Qing [7 ]
Wu, Yutong [1 ]
Vadgama, Jaydutt V. [2 ,3 ]
Wu, Yong [2 ,3 ]
机构：
[1] Bluewater Biotech LLC, POB 1010, New Providence, NJ 07974 USA
[2] Charles Drew Univ Med & Sci, David Geffen UCLA Sch Med, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90095 USA
[3] UCLA Jonsson Comprehens Canc Ctr, 1748 E 118th St, Los Angeles, CA 90095 USA
[4] Guangdong Prov Peoples Hosp, Canc Ctr, Dept Breast Canc, Guangzhou 510080, Guangdong, Peoples R China
[5] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China
[6] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Oncol, Shanghai 200123, Peoples R China
[7] Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
来源：
CANCER COMMUNICATIONS | 2022年 / 42卷 / 07期
关键词：
D O I：
10.1002/cac2.12296
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 667
页数：5
相关论文
共 50 条
  • [41] Everolimus for Estrogen Receptor-negative Breast Cancer Prevention: A Journey Begun?
    Nye, Lauren
    Khan, Seema A.
    CANCER PREVENTION RESEARCH, 2022, 15 (12) : 787 - 790
  • [42] Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
    Kang, Byung-Hee
    Jang, Bum-Sup
    Kim, In Ah
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (03) : 479 - 488
  • [43] Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer
    Iravani, Omid
    Yip, George Wai-Cheong
    Thike, Aye Aye
    Chua, Pei Jou
    Scully, Olivia Jane
    Tan, Puay-Hoon
    Bay, Boon-Huat
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (10) : 878 - 883
  • [44] Parity and breastfeeding associations with familial estrogen receptor-negative breast cancer
    Dibbell, Mattie
    Erwin, Deborah
    Johnson, Detric
    Jandorf, Lina
    Ray, Veronica Meadows
    Ochs-Balcom, Heather
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (02)
  • [45] Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
    Byung-Hee Kang
    Bum-Sup Jang
    In Ah Kim
    Breast Cancer Research and Treatment, 2023, 197 : 479 - 488
  • [46] SINOPHOBIC GROWTH IN ESTROGEN RECEPTOR-NEGATIVE METASTATIC BREAST-CANCER
    HARTVEIT, F
    THORSEN, T
    TANGEN, M
    MOEHLE, BO
    THORESEN, S
    HALVORSEN, JF
    ONCOLOGY, 1983, 40 (04) : 241 - 243
  • [47] Does Microenvironment Contribute to the Etiology of Estrogen Receptor-Negative Breast Cancer?
    Barcellos-Hoff, Mary Helen
    CLINICAL CANCER RESEARCH, 2013, 19 (03) : 541 - 548
  • [48] Prognostic significance of transforming growth factor β receptor II in estrogen receptor-negative breast cancer patients
    Buck, MB
    Fritz, P
    Dippon, J
    Zugmaier, G
    Knabbe, C
    CLINICAL CANCER RESEARCH, 2004, 10 (02) : 491 - 498
  • [49] Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?
    Chen, J. -H.
    Hsu, F. -T.
    Shih, H. -N.
    Hsu, C. -C.
    Chang, D.
    Nie, K.
    Nalcioglu, O.
    Su, M. -Y.
    ANNALS OF ONCOLOGY, 2009, 20 (08) : 1447 - 1449
  • [50] Differences in estrogen receptor-negative breast cancer by race and SEER registry
    Lynn, Brittny C. Davis
    Chernyavskiy, Pavel
    Anderson, William F.
    Gierach, Gretchen L.
    Rosenberg, Philip S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
12345